We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.72B
AUM Growth
+$589M
Cap. Flow
-$37.2M
Cap. Flow %
-0.38%
Top 10 Hldgs %
31.39%
Holding
419
New
23
Increased
181
Reduced
152
Closed
9

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$48.3M
2
ABBV icon
AbbVie
ABBV
+$40.8M
3
SRE icon
Sempra
SRE
+$23.4M
4
CVX icon
Chevron
CVX
+$21.9M
5
HPQ icon
HP
HPQ
+$21.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$72M
2
ENB icon
Enbridge
ENB
+$61.3M
3
MSFT icon
Microsoft
MSFT
+$45.4M
4
KMB icon
Kimberly-Clark
KMB
+$42.1M
5
VIRT icon
Virtu Financial
VIRT
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Healthcare 16.37%
3 Financials 13.94%
4 Industrials 11.5%
5 Consumer Staples 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SABR icon
201
Sabre
SABR
$731M
$2.25M 0.02%
109,858
+39,182
+55% +$750K
PF
202
DELISTED
Pinnacle Foods, Inc.
PF
$2.24M 0.02%
37,741
+8,366
+28% +$472K
ORCL icon
203
Oracle
ORCL
$374B
$2.18M 0.02%
46,086
+800
+2% +$39.2K
RAVN
204
DELISTED
Raven Industries Inc
RAVN
$2.17M 0.02%
63,336
-345
-0.5% -$11.8K
FLO icon
205
Flowers Foods
FLO
$1.49B
$2.15M 0.02%
111,338
+32,186
+41% +$618K
IJH icon
206
iShares Core S&P Mid-Cap ETF
IJH
$122B
$2.14M 0.02%
56,420
-680
-1% -$25.1K
CBRL icon
207
Cracker Barrel
CBRL
$1.26B
$2.09M 0.02%
13,161
+2,659
+25% +$417K
CNK icon
208
Cinemark Holdings
CNK
$4.24B
$2.09M 0.02%
60,013
+6,054
+11% +$215K
IWM icon
209
iShares Russell 2000 ETF
IWM
$79.8B
$2.06M 0.02%
13,508
+5,202
+63% +$781K
PDCO
210
DELISTED
Patterson Companies, Inc.
PDCO
$2.05M 0.02%
56,638
+4,607
+9% +$168K
LMAT icon
211
LeMaitre Vascular
LMAT
$2.32B
$2.03M 0.02%
63,825
+820
+1% +$28.1K
TCF
212
DELISTED
TCF Financial Corporation Common Stock
TCF
$2.02M 0.02%
+37,872
New +$2.04M
NVEC icon
213
NVE Corp
NVEC
$562M
$2.02M 0.02%
23,466
-50
-0.2% -$4.2K
BCE icon
214
BCE
BCE
$20.2B
$2.01M 0.02%
41,852
-113
-0.3% -$5.38K
GILD icon
215
Gilead Sciences
GILD
$162B
$1.99M 0.02%
27,716
+3,000
+12% +$228K
VWO icon
216
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$1.98M 0.02%
43,102
+8,805
+26% +$394K
USPH icon
217
US Physical Therapy
USPH
$1.2B
$1.97M 0.02%
27,335
+700
+3% +$47.8K
PSMT icon
218
Pricesmart
PSMT
$5.98B
$1.95M 0.02%
22,610
-140
-0.6% -$12K
WST icon
219
West Pharmaceutical
WST
$24B
$1.91M 0.02%
19,363
-2,075
-10% -$203K
TPL icon
220
Texas Pacific Land
TPL
$27.8B
$1.88M 0.02%
37,800
– –
UFPI icon
221
UFP Industries
UFPI
$4.9B
$1.87M 0.02%
49,790
+1,010
+2% +$37.1K
MDSO
222
DELISTED
Medidata Solutions, Inc.
MDSO
$1.81M 0.02%
28,505
+7,279
+34% +$519K
HI
223
DELISTED
Hillenbrand
HI
$1.8M 0.02%
40,170
– –
BF.B icon
224
Brown-Forman Class B
BF.B
$13.2B
$1.78M 0.02%
40,513
– –
MEI icon
225
Methode Electronics
MEI
$496M
$1.77M 0.02%
44,200
-915
-2% -$40.8K
7 8
9
10 11

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q4 2017 Portfolio in Review

As of Q4 2017, Bahl & Gaynor held 419 positions worth $9.72B, up 6.4% from $9.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2017 filing shows 23 new, 181 increased, 152 reduced and 9 closed positions. Its largest new stake was iShares Core High Dividend ETF: 534,010 shares worth $9.63M. The largest sale was Merck, an estimated $72M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2017 buy was iShares Core High Dividend ETF: 534,010 shares worth $9.63M.
  • Bahl & Gaynor added most to Amgen in Q4 2017, an estimated $48.3M increase.
  • Bahl & Gaynor's biggest Q4 2017 reduction was Merck, cutting an estimated $72M.
  • Bahl & Gaynor fully exited Virtu Financial in Q4 2017, selling an estimated $10.4M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $9.72B portfolio in Q4 2017.
  • Bahl & Gaynor opened 23 new positions and closed 9 in Q4 2017.
  • Bahl & Gaynor's portfolio value rose 6.4% quarter-over-quarter to $9.72B.

Based on Bahl & Gaynor's 13F filing for Q4 2017, filed 13 Feb 2018.